Treating a patient with substance abuse disorders can be challenging enough, but sometimes the patient not only suffers from a substance use disorder, but also has an independent psychiatric disorder. On Monday, Julie A Kmiec, DO, will help shed some light on how to differentiate between substance-induced psychiatric disorders and independent psychiatric disorders in her session “Co-occurring Disorders: Substance Induced vs. Primary Psychiatric Disorder,” part of the American Osteopathic Academy of Addiction Medicine (AOAAM) program.
The session starts at 1:30 p.m. in Room 5 on the second floor of the convention center. “I will review the epidemiology of psychiatric disorders in individuals with substance use disorders, and discuss effective treatments of co-occurring disorders,” said Dr. Kmiec, who is assistant professor of psychiatry at the University of Pittsburgh and President-Elect of AOAAM.
Dr. Kmiec said making an accurate diagnosis is important because independent psychiatric disorders, such as mood, anxiety, or psychotic disorders, require different treatment than substance-induced disorders.
“Research on the prevalence of psychiatric disorders in patients with substance use disorders will be discussed, as well as treatment of relatively common psychiatric disorders (e.g., depressive and anxiety disorders) in patients with substance use disorders,” she said.
At the end of the session, participants should be able to take a history that will allow one to make accurate diagnoses, and treat individuals with co-occurring disorders with effective medications, she added.